retatrutide mechanism retatrutide clinical trials 2024 2025 trial results press release A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity Lilly's triple agonist, retatrutide, delivered – Retatrutide: A Triple Agonist Shaping

US$ 27.46

★★★★★ 4.9 (24 reviews)

US$ 23.86

★★★★★ 4.4 (8 reviews)

US$ 22.31

★★★★★ 4.6 (11 reviews)

US$ 22.17

★★★★★ 4.5 (5 reviews)

US$ 24.88

★★★★★ 4.2 (18 reviews)

US$ 21.03

★★★★★ 4.4 (14 reviews)

US$ 25.12

★★★★★ 4.3 (12 reviews)

US$ 26.80

★★★★★ 4.5 (28 reviews)

US$ 26.05

★★★★★ 5.0 (17 reviews)

US$ 23.86

★★★★★ 4.4 (29 reviews)

US$ 26.07

★★★★★ 4.5 (27 reviews)

US$ 22.76

★★★★★ 4.9 (25 reviews)

US$ 21.85

★★★★★ 4.9 (19 reviews)

US$ 27.45

★★★★★ 4.1 (29 reviews)

US$ 21.75

★★★★★ 4.2 (5 reviews)

US$ 26.21

★★★★★ 4.0 (13 reviews)

US$ 22.55

★★★★★ 4.4 (24 reviews)

US$ 25.89

★★★★★ 4.2 (19 reviews)

US$ 23.13

★★★★★ 4.8 (18 reviews)

US$ 21.65

★★★★★ 4.9 (23 reviews)